Acurx Pharmaceuticals shares are trading higher after the company announced it was granted new patents covering its DNA Polymerase IIIC inhibitors by the Mexican and Japanese patent offices.

Benzinga Newsdesk www.benzinga.com Positive 95.3%

Neg 0% Neu 0% Pos 95.3%

Comments

No comments yet. Be the first!